Open original FDA record ↗Recall record
- FDA identifier
- Z-1063-2024
- Company in FDA record
- Vyaire Medical
- FDA classification date
- Feb 25, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Risk of hypoventilation caused by duckbill and ring broken/disassembled, due to faulty mold/tooling producing out of specification components. Device failure may cause improper ventilation or no ventilation that may result in hypoventilation or hypoxia, and potentially lead to death. The mold/tooling used to produce the affected component was replaced in 2017.
Source facts
- Action
- Vyaire issued an URGENT: Customer notification Letter to its consignees on 01/10/2024 via letter delivered by UPS Next Day Air. The notice explained the problem, complaints received, and requested the consignee discard or destroy all affected devices. If the consignee further distributed the product, they were directed to forward a copy of the notice to those parties.
- Initiated
- 2024-01-10
- Root cause
- Process control
- Distribution
- Worldwide distribution. US nationwide, Brazil, Canada, Switzerland, France, UK, Mexico, Netherlands, Saudi Arabia, Sweden, and South Africa
- Recall number
- Z-1063-2024
- Recall status
- Open, Classified
- CDRH record ID
- 205571
- FDA classified
- 2024-02-25
- Recall event number
- 93821